| |
Sixth
GAVI Board Meeting, 17 October 2001, Ottawa, Canada
October 2001
6. Other Business
- UNICEF confirmed that the availability of combination
DTP-hepB and DTP-hepB-Hib vaccines for 2002 had been reduced from
30 million to 20 million doses. It was estimated that this reduced
quantity would be sufficient for those countries that had already
started the introduction of these vaccines, but that no new countries
would be able to introduce combination DTP-hepB or DTP-hepB-Hib
vaccines during 2002. The situation for 2003 would be clearer
by end-2001.
- UNICEF also confirmed the relative scarcity of
yellow fever vaccine during 2001 and that the priority had been
to build up a 2 million dose stockpile, in close collaboration
with WHO and other partners in the Inter-agency Consultative Group
(ICG) that was set up to monitor outbreak response. The stockpile
had enabled immediate support to the Côte d’Ivoire
outbreak earlier this year. In addition, three countries had received
small quantities of vaccines based on GAVI approvals. Availability
for 2002 and beyond was considerably greater which would enable
good response to those countries applying for yellow fever vaccine
through GAVI.
- The Board welcomed the announcement made by Canada
Minister for International Cooperation Maria Minna that Canada
would be contributing US $6.4 million ($10 million Canadian) to
The Vaccine Fund over three years and that the amount would be
re-evaluated at the government’s next budget meeting in February
2002.
- The Board appreciated the presentation given by
American Red Cross Senior Technical Advisor Mark Grabowsky at
the dinner preceding the Board meeting, which outlined his organization’s
commitment to measles control efforts.
- The next teleconference to discuss the recommendations
from the independent review committee based on the 5th round of
proposal review will be held during the week of 26-30 November
2001.
- The next meeting of the Board will be on
19-20 June 2002. Location still to be determined, depending on
the location of the Partners’ meeting later in the year –
at least one of the Board meetings should be held in a developing
country. Suggestions for agenda items include:
- reports from the field: Asia
- review of Vaccine Fund strategic plan
- research & development
- opening Window 3
- progress on strengthening NGO involvement in
GAVI
- the role of GAVI in middle-income countries
- capacity building
- financial sustainability
- alignment with accelerated disease control
initiatives
- In order to allow for adequate consultation, documents
for the next Board meeting will need to be circulated well in
advance.
|
